Free Trial
→ Your book attached (From Profits Run) (Ad)tc pixel
OTCMKTS:AMBBY

Ambu A/S Q3 2026 Earnings Results & Report

Ambu A/S logo
$11.00 0.00 (0.00%)
As of 10/9/2026

Ambu A/S reported Q3 2026 earnings on August 25, 2026. The company reported EPS of $0.09, while revenue was $255.12 million.

Research:ProfileEarnings HistoryForecast

Earnings Announcement Details

Quarter
Q3 2026
Report Date
Time
Before Market Opens

Ambu A/S EPS Results

Actual EPS
$0.09
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Ambu A/S Revenue Results

Actual Revenue
$255.12 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Ambu A/S Q3 2026 Earnings FAQ

Ambu A/S (OTCMKTS:AMBBY) reported earnings of $0.09 per share for Q3 2026. The report was announced on Tuesday, August 25, 2026.

Ambu A/S reported revenue of $255.12 million for Q3 2026.

Ambu A/S Earnings Headlines

Ambu AS ADR AMBBY
August 28, 2026  |  morningstar.comM
3 European Stocks Estimated To Be Undervalued By Up To 47.6%
November 18, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/3-european-stocks-estimated-undervalued-053805496.html
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel
October 11 at 1:00 AM  |  Base Camp Trading (Ad)
European Growth Companies With Up To 34% Insider Ownership
November 14, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/european-growth-companies-34-insider-053539319.html
Ambu (CPSE:AMBU B) Valuation: How Improved Results and Guidance Shape Investor Sentiment
November 13, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/ambu-cpse-ambu-b-valuation-031456510.html
Did Strong Results and New Guidance Just Shift Ambu's (CPSE:AMBU B) Investment Narrative?
November 13, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/did-strong-results-guidance-just-111317861.html
See More Ambu A/S Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Ambu A/S? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ambu A/S and other key companies, straight to your email.

About Ambu A/S

Ambu A/S (OTCMKTS:AMBBY) is a Danish medical device company that develops, manufactures and markets single-use products for hospitals, clinics and emergency care providers. Its portfolio includes disposable endoscopes and visualization systems used in areas such as bronchoscopy, gastrointestinal procedures, urology, ear, nose and throat care, and anesthesia.

The company also supplies products for airway management, patient monitoring and emergency care, including electrodes, resuscitation equipment and training manikins. Ambu’s single-use products are designed to support infection prevention, simplify clinical workflows and reduce the need for reprocessing reusable equipment.

Founded in 1937, Ambu has its headquarters in Ballerup, Denmark, and serves healthcare customers internationally through operations and distribution networks across Europe, North America, the Asia-Pacific region and other global markets. The company is led by Chief Executive Officer Britt Meelby Jensen.

View Ambu A/S Profile
Earnings Tools